Drugs Made In America Acquisition II

DMII · NASDAQ

$10.19+$0.00 (+0.00%)TodayMarket closed · Oct 23, 4:00 PM ET

No price history for this range.

About DMII

Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenue to date.

Employees: 0
Headquarters: Fort Lauderdale, Florida
Listed: Sep 25, 2025
Sector: N/A
Industry: N/A

Leadership

Drugs Made In America Acquisition II executives
Name	Title	Since	Age
Lynn Stockwell	—	2024	69
Saleem Elmasri	—	—	39
Glenn Worman	—	2025	66
Catherine Do	—	—	45
G. Sridhar Prasad	—	—	62
Myron Shulgan	—	—	79

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.